Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response.

MLA

Kumar, Yogesh, et al. “Massive Interstitial Copy-Neutral Loss-of-Heterozygosity as Evidence for Cancer Being a Disease of the DNA-Damage Response.” BMC Medical Genomics, vol. 8, no. 1, June 2015, pp. 1–21. EBSCOhost, https://doi.org/10.1186/s12920-015-0104-2.

APA

Kumar, Y., Jianfeng Yang, Taobo Hu, Lei Chen, Zhi Xu, Lin Xu, Xiao-Xia Hu, Gusheng Tang, Jian-Min Wang, Yi Li, Wai-Sang Poon, Weiqing Wan, Liwei Zhang, Wai-Kin Mat, Pun, F. W., Peggy Lee, Cheong, T. H. Y., Xiaofan Ding, Siu-Kin Ng, & Shui-Ying Tsang. (2015). Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response. BMC Medical Genomics, 8(1), 1–21. https://doi.org/10.1186/s12920-015-0104-2

Chicago

Kumar, Yogesh, Jianfeng Yang, Taobo Hu, Lei Chen, Zhi Xu, Lin Xu, Xiao-Xia Hu, et al. 2015. “Massive Interstitial Copy-Neutral Loss-of-Heterozygosity as Evidence for Cancer Being a Disease of the DNA-Damage Response.” BMC Medical Genomics 8 (1): 1–21. doi:10.1186/s12920-015-0104-2.